Cancers, Free Full-Text

Imatinib became the standard treatment for chronic myeloid leukemia (CML) about 20 years ago, which was a major breakthrough in stabilizing the pathology and improving the quality of life of patients. However, the emergence of resistance to imatinib and other tyrosine kinase inhibitors leads researchers to characterize new therapeutic targets. Several studies have highlighted the role of histone deacetylase 6 (HDAC6) in various pathologies, including cancer. This protein effectively intervenes in cellular activities by its primarily cytoplasmic localization. In this review, we will discuss the molecular characteristics of the HDAC6 protein, as well as its overexpression in CML leukemic stem cells, which make it a promising therapeutic target for the treatment of CML.

Cancer Free – Heaven Sent Greeting Cards

Free Breast Cancer Treatment - Colaboratory

What is secondary lung cancer?

Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study - The Lancet Global Health

National Comprehensive Cancer Network - Home

Hypercalcemia and treated breast cancers: The diagnostic dilemma – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.

Pathology Outlines - Carcinoma-general

Kidney Cancer Text · Free Stock Photo

Mother find out dying child is cancer free ❤️, Cancer Free